|
Gordon Christopher R
|
Non-Executive Director |
Cerevel Therapeutics Holdings, Inc. (CERE)
|
2023-10-16 |
$22.81 |
97.1% |
$121,383,146
|
5,480,052
|
$124,999,986 |
|
Koppel Adam
|
Non-Executive Director |
Cerevel Therapeutics Holdings, Inc. (CERE)
|
2023-10-16 |
$22.81 |
97.1% |
$121,383,146
|
5,480,052
|
$124,999,986 |
|
Sarofim Christopher Binyon
|
Non-Executive Director |
Sable Offshore Corp. (SOC)
|
2024-02-14 |
$10.00 |
116.1% |
$69,660,006
|
6,000,000
|
$60,000,000 |
|
Ra Capital Management, L.P.
|
Non-Executive Director |
Eliem Therapeutics, Inc. (ELYM)
|
2024-06-27 |
$3.84 |
97.1% |
$48,521,877
|
13,008,546
|
$49,952,817 |
|
Emanuel Ariel
|
Chief Executive Officer |
TKO Group Holdings, Inc. (TKO)
|
2024-04-09 |
$89.01 |
30.5% |
$44,655,928
|
1,642,970
|
$146,240,760 |
|
Flores James C
|
Chairman |
Sable Offshore Corp. (SOC)
|
2024-02-14 |
$10.01 |
115.9% |
$37,330,123
|
3,217,500
|
$32,200,055 |
|
Soni Manmeet Singh
|
Chief Operating Officer |
Summit Therapeutics Inc. (SMMT)
|
2023-10-13 |
$1.68 |
644.0% |
$32,202,376
|
2,976,190
|
$4,999,999 |
|
Lichter Jay
|
Non-Executive Director |
Janux Therapeutics, Inc. (JANX)
|
2023-11-13 |
$5.87 |
644.6% |
$32,158,475
|
849,854
|
$4,988,643 |
|
Kersten Dirk
|
Non-Executive Director |
Dyne Therapeutics, Inc. (DYN)
|
2024-01-09 |
$17.50 |
92.3% |
$27,685,706
|
1,714,285
|
$29,999,988 |
|
Rothbaum Wayne P.
|
Non-Executive Director |
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
|
2023-09-15 |
$5.30 |
97.4% |
$25,800,000
|
5,000,000
|
$26,500,000 |
|
Ra Capital Management, L.P.
|
Non-Executive Director |
ARS Pharmaceuticals, Inc. (SPRY)
|
2023-09-21 |
$3.03 |
287.7% |
$23,541,474
|
2,700,000
|
$8,183,526 |
|
Katabi Maha
|
Non-Executive Director |
RayzeBio, Inc. (RYZB)
|
2023-09-19 |
$18.00 |
247.2% |
$21,009,158
|
472,222
|
$8,499,996 |
|
Purcell Paul Martin
|
Non-Executive Director |
Sezzle Inc. (SEZL)
|
2023-11-27 |
$1.66 |
8243.9% |
$20,835,900
|
152,562
|
$252,744 |
|
Cui Xiangmin
|
Non-Executive Director |
ALPINE IMMUNE SCIENCES, INC. (ALPN)
|
2023-11-09 |
$12.50 |
419.8% |
$19,676,250
|
375,000
|
$4,687,500 |
|
Perceptive Advisors Llc
|
Non-Executive Director |
Cerevel Therapeutics Holdings, Inc. (CERE)
|
2023-10-16 |
$22.81 |
97.1% |
$19,421,296
|
876,808
|
$19,999,990 |
|
Jagid Jeffrey M
|
Chief Executive Officer |
ATLANTIC INTERNATIONAL CORP. (ATLN)
|
2024-06-18 |
$2.36 |
196.6% |
$17,331,184
|
3,735,169
|
$8,814,999 |
|
Wallace Rory
|
Non-Executive Director |
Barnes & Noble Education, Inc. (BNED)
|
2024-06-10 |
$5.00 |
147.0% |
$14,882,337
|
2,024,808
|
$10,124,039 |
|
Bvf Partners L P/Il
|
Non-Executive Director |
Kymera Therapeutics, Inc. (KYMR)
|
2023-11-03 |
$12.80 |
264.0% |
$13,995,967
|
414,105
|
$5,301,325 |
|
Jana Partners Management, Lp
|
Non-Executive Director |
MERCURY SYSTEMS INC (MRCY)
|
2024-02-09 |
$27.90 |
34.7% |
$12,931,011
|
1,335,848
|
$37,270,159 |
|
Gupta Ravi
|
Non-Executive Director |
Maplebear Inc. (CART)
|
2024-02-22 |
$28.54 |
21.3% |
$12,286,139
|
2,020,273
|
$57,655,710 |
|
Purcell Paul Martin
|
Non-Executive Director |
Sezzle Inc. (SEZL)
|
2023-09-28 |
$2.19 |
6207.1% |
$11,429,668
|
84,018
|
$184,139 |
|
Levan Jarett
|
CEO and President |
BBX Capital, Inc. (B)
|
2024-02-02 |
$11.08 |
240.0% |
$11,045,352
|
415,395
|
$4,602,577 |
|
Baker Bros. Advisors Lp
|
Non-Executive Director |
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
|
2023-11-14 |
$146.99 |
67.4% |
$10,643,733
|
107,499
|
$15,801,021 |
|
Perceptive Advisors Llc
|
Non-Executive Director |
Solid Biosciences Inc. (SLDB)
|
2024-01-11 |
$5.53 |
53.9% |
$10,163,925
|
3,410,713
|
$18,861,243 |
|
Purcell Paul Martin
|
Non-Executive Director |
Sezzle Inc. (SEZL)
|
2023-11-22 |
$1.69 |
8057.5% |
$9,223,519
|
67,554
|
$114,471 |
|
Purcell Paul Martin
|
Non-Executive Director |
Sezzle Inc. (SEZL)
|
2023-11-30 |
$1.67 |
8193.8% |
$9,013,180
|
66,000
|
$110,000 |
|
Doak Michael
|
Non-Executive Director |
TWFG, Inc. (TWFG)
|
2024-07-19 |
$17.00 |
81.9% |
$8,188,231
|
588,235
|
$9,999,995 |
|
Botha Roelof
|
Non-Executive Director |
Block, Inc. (SQ)
|
2023-11-13 |
$50.89 |
26.9% |
$7,399,801
|
540,646
|
$27,515,119 |
|
Low Check Kian
|
Non-Executive Director |
Broadcom Inc. (AVGO)
|
2023-09-06 |
$87.20 |
75.2% |
$7,217,919
|
110,000
|
$9,592,282 |
|
Chan Shiu Leung
|
Non-Executive Director |
Super Micro Computer, Inc. (SMCI)
|
2024-02-01 |
$56.80 |
629.9% |
$7,156,000
|
20,000
|
$1,136,000 |
|
Coric Vlad
|
Chief Executive Officer |
Biohaven Ltd. (BHVN)
|
2023-10-05 |
$22.00 |
67.8% |
$6,781,810
|
454,545
|
$9,999,990 |
|
Childs John W
|
Non-Executive Director |
Biohaven Ltd. (BHVN)
|
2023-10-05 |
$22.00 |
67.8% |
$6,781,810
|
454,545
|
$9,999,990 |
|
Purcell Paul Martin
|
Non-Executive Director |
Sezzle Inc. (SEZL)
|
2023-12-05 |
$1.67 |
8193.8% |
$6,555,040
|
48,000
|
$80,000 |
|
Rothbaum Wayne P.
|
Non-Executive Director |
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
|
2024-02-20 |
$9.15 |
14.3% |
$6,550,000
|
5,000,000
|
$45,750,000 |
|
Purcell Paul Martin
|
Non-Executive Director |
Sezzle Inc. (SEZL)
|
2023-11-20 |
$1.79 |
7600.8% |
$6,385,158
|
46,800
|
$84,006 |
|
Purcell Paul Martin
|
Non-Executive Director |
Sezzle Inc. (SEZL)
|
2023-11-15 |
$1.90 |
7157.4% |
$5,709,304
|
41,880
|
$79,768 |
|
Fertitta Lorenzo J
|
Vice President |
Red Rock Resorts, Inc. (RRR)
|
2024-05-13 |
$50.39 |
13.8% |
$5,567,998
|
800,000
|
$40,312,000 |
|
Morfit G Mason
|
Non-Executive Director |
Salesforce, Inc. (CRM)
|
2024-06-03 |
$233.17 |
5.6% |
$5,542,598
|
428,000
|
$99,796,760 |
|
Perceptive Advisors Llc
|
Non-Executive Director |
Astria Therapeutics, Inc. (ATXS)
|
2023-10-16 |
$6.51 |
76.2% |
$5,336,503
|
1,074,608
|
$6,999,997 |
|
Song Hong Fang
|
Non-Executive Director |
CG Oncology, Inc. (CGON)
|
2024-01-29 |
$19.00 |
97.7% |
$4,884,194
|
263,157
|
$4,999,983 |
|
Purcell Paul Martin
|
Non-Executive Director |
Sezzle Inc. (SEZL)
|
2023-12-04 |
$1.68 |
8128.0% |
$4,651,985
|
34,068
|
$57,234 |
|
D1 Capital Partners L.P.
|
Non-Executive Director |
Maplebear Inc. (CART)
|
2023-09-21 |
$30.00 |
15.4% |
$4,619,999
|
1,000,000
|
$30,000,000 |
|
Baker Bros. Advisors Lp
|
Non-Executive Director |
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
|
2023-11-20 |
$178.11 |
38.1% |
$4,554,154
|
67,079
|
$11,947,280 |
|
Simpkins Neil P
|
Non-Executive Director |
Gates Industrial Corp plc (GTES)
|
2024-02-16 |
$12.20 |
36.6% |
$4,470,000
|
1,000,000
|
$12,200,000 |
|
Baker Bros. Advisors Lp
|
Non-Executive Director |
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
|
2023-11-15 |
$158.13 |
55.6% |
$4,339,643
|
49,387
|
$7,809,559 |
|
Silvester Dominic Francis Michael
|
Chief Executive Officer |
Enstar Group LTD (ESGR)
|
2023-11-07 |
$227.18 |
40.8% |
$4,175,100
|
45,000
|
$10,223,100 |
|
Ebsworth David R
|
Non-Executive Director |
Verona Pharma plc (VRNA)
|
2023-11-06 |
$1.98 |
1268.3% |
$4,008,720
|
160,000
|
$316,080 |
|
Perceptive Advisors Llc
|
Non-Executive Director |
Astria Therapeutics, Inc. (ATXS)
|
2023-12-21 |
$6.20 |
85.2% |
$3,907,200
|
740,000
|
$4,588,000 |
|
Healy James
|
Non-Executive Director |
ArriVent Biopharma, Inc. (AVBP)
|
2024-01-30 |
$18.00 |
47.8% |
$3,822,218
|
444,444
|
$7,999,992 |
|
Gordon Carl L
|
Non-Executive Director |
ArriVent Biopharma, Inc. (AVBP)
|
2024-01-30 |
$18.00 |
47.8% |
$3,822,218
|
444,444
|
$7,999,992 |